| Year | Firm | Client | Income | Doc |
|---|---|---|---|---|
| 2026 AMENDED |
DLA PIPER LLP (US) | PONYA DIAGNOSTICS, LLC | $80,000 | |
| 2026 Registration |
DLA PIPER LLP (US) | RAINFALL HEALTH | — | |
| 2026 2nd Quarter - Report |
DLA PIPER LLP (US) | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMER… | $60,000 | |
| 2026 2nd Quarter - Report |
DLA PIPER LLP (US) | BIOGEN, INC. | $60,000 | |
| 2026 2nd Quarter - Report |
DLA PIPER LLP (US) | IQVIA HOLDINGS, INC. | $60,000 | |
| 2026 2nd Quarter - Report |
DLA PIPER LLP (US) | DUKE UNIVERSITY | $80,000 | |
| 2026 2nd Quarter - Report |
DLA PIPER LLP (US) | PONYA DIAGNOSTICS, LLC | $80,000 | |
| 2026 2nd Quarter - Report |
DLA PIPER LLP (US) | REGENXBIO INC. | $60,000 | |
| 2026 2nd Quarter - Report |
DLA PIPER LLP (US) | AVALYN PHARMA INC. | $60,000 | |
| 2026 2nd Quarter - Report |
DLA PIPER LLP (US) | CORVENT MEDICAL, INC. | $60,000 |